ImmunityBio, Inc. (IBRX)
7.30
+0.16
(+2.24%)
USD |
NASDAQ |
Apr 02, 16:00
7.25
-0.05
(-0.68%)
After-Hours: 20:00
ImmunityBio Profit Margin (Quarterly) : -161.8% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | 18.15% |
| Gilead Sciences, Inc. | 27.44% |
| Iovance Biotherapeutics, Inc. | -82.92% |
| Krystal Biotech, Inc. | 47.99% |
| Arcellx, Inc. | -3.51K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -83.30% |
| Return on Invested Capital | -118.0% |
| Gross Profit Margin (Quarterly) | 88.91% |
| Operating Margin (Quarterly) | -169.0% |
| Return on Net Operating Assets | -152.4% |